4.6 Article

Survival After Liver Transplantation: An International Comparison Between the United States and the United Kingdom in the Years 2008-2016

期刊

TRANSPLANTATION
卷 106, 期 7, 页码 1390-1400

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0000000000003978

关键词

-

资金

  1. National Health Service (NHS) National Specialized Commissioning Group
  2. NHS England
  3. Doctoral Research Fellowship from the National Institute of Health Research
  4. NHS National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North Thames at Bart's Health NHS Trust

向作者/读者索取更多资源

Compared to the United States, the United Kingdom has seen improvements in short-term and long-term mortality rates following liver transplantation. This study aimed to compare the mortality rates of liver transplant recipients in both countries and found that the United Kingdom had lower mortality rates after 90 days. This international comparison study helps identify differences in healthcare delivery and provides benchmarking for improved global outcomes in liver transplantation.
Background. Compared with the United States, risk-adjusted mortality in the United Kingdom has historically been worse in the first 90 d following liver transplantation (LT) and better thereafter. In the last decade, there has been considerable change in the practice of LT internationally, but no contemporary large-scale international comparison of posttransplant outcomes has been conducted. This study aimed to determine disease-specific short- and long-term mortality of LT recipients in the United States and the United Kingdom. Methods. This retrospective international multicenter cohort study analyzed adult (>= 18 y) first-time LT recipients between January 2, 2008, and December 31, 2016, using the Organ Procurement and Transplantation Network/United Network for Organ Sharing and the UK Transplant Registry databases. Time-dependent Cox regression estimated hazard ratios (HRs) comparing disease-specific risk-adjusted mortality in the first 90 d post-LT, between 90 d and 1 y, and between 1 and 5 y. Results. Forty-two thousand eight hundred seventy-four US and 4950 UK LT recipients were included. The main LT indications in the United States and the United Kingdom were hepatocellular carcinoma (25.4% and 24.9%, respectively) and alcohol-related liver disease (20.3% and 27.1%, respectively). There were no differences in mortality during the first 90 d post-LT (reference: United States; HR, 0.96; 95% confidence interval [CI], 0.82-1.12). However, between 90 d and 1 y (HR, 0.71; 95% CI, 0.59-0.85) and 1 and 5 y (HR, 0.71; 95% CI, 0.63-0.81]) the United Kingdom had lower mortality. The mortality differences between 1 and 5 y were most marked in hepatocellular carcinoma (HR, 0.71; 95% CI, 0.58-0.88) and alcohol-related liver disease patients (HR, 0.64; 95% CI, 0.45-0.89). Conclusions. Risk-adjusted mortality in the United States and the United Kingdom was similar in the first 90 d post-LT but better in the United Kingdom thereafter. International comparisons of LT may highlight differences in healthcare delivery and help benchmarking by identifying modifiable factors that can facilitate improved global outcomes in LT.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据